1. Home
  2. ALB vs RGEN Comparison

ALB vs RGEN Comparison

Compare ALB & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Albemarle Corporation

ALB

Albemarle Corporation

HOLD

Current Price

$141.50

Market Cap

17.2B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$164.06

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALB
RGEN
Founded
1994
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2B
8.2B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
ALB
RGEN
Price
$141.50
$164.06
Analyst Decision
Hold
Buy
Analyst Count
20
10
Target Price
$109.68
$174.90
AVG Volume (30 Days)
2.9M
566.0K
Earning Date
02-11-2026
02-19-2026
Dividend Yield
1.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$4,946,415,000.00
$707,890,000.00
Revenue This Year
N/A
$17.84
Revenue Next Year
$3.34
$12.44
P/E Ratio
N/A
$5,307.14
Revenue Growth
N/A
11.74
52 Week Low
$49.43
$102.97
52 Week High
$152.08
$182.52

Technical Indicators

Market Signals
Indicator
ALB
RGEN
Relative Strength Index (RSI) 61.38 53.89
Support Level $141.25 $161.41
Resistance Level $152.08 $167.65
Average True Range (ATR) 4.78 4.48
MACD -0.54 0.01
Stochastic Oscillator 52.32 68.63

Price Performance

Historical Comparison
ALB
RGEN

About ALB Albemarle Corporation

Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: